Evidence map›Paper›PMID 36279473›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

TNFα and IFNγ cooperate for efficient pro- to anti-inflammatory transition of macrophages during muscle regeneration.

Farshad Babaeijandaghi, Adrianna Paiero, Reece Long, Lin Wei Tung, Shannon Percival Smith, Ryan Cheng, Joshua Smandych, Nasim Kajabadi, Chih-Kai Chang, Amirhossein Ghassemi and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. A who's who of cell types in skeletal muscle.Communications biology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Macrophages and the Survival of Cardiomyocytes After Myocardial Infarction.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Skeletal Muscle and the Immune System.Advances in experimental medicine and biology · 2025
    Review
  18. Article
  19. Article
  20. DPPIVNature communications · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 2 countries.

Farshad BabaeijandaghiBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.ORCID 0000-0001-6920-2450
Adrianna PaieroBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Reece LongBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Lin Wei TungBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Shannon Percival SmithBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Ryan ChengBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.ORCID 0000-0003-0068-6471
Joshua SmandychBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.ORCID 0000-0003-1873-0696
Nasim KajabadiBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Chih-Kai ChangBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Amirhossein GhassemiBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
William D M KennedyBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Hesham SolimanBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.
Peter W SchutzDepartment of Pathology, University of British Columbia and Vancouver General Hospital, Vancouver, BC, V6T 2B5, Canada.
Fabio M V RossiBiomedical Research Centre, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada.ORCID 0000-0002-0368-2620
University of British Columbia · CA

Funding

Gouvernement du Canada | Canadian Institutes of Health Research (IRSC) CIHR-FDN-159908
6 · The paper itself

Abstract

IFNγ is traditionally known as a proinflammatory cytokine with diverse roles in antimicrobial and antitumor immunity. Yet, findings regarding its sources and functions during the regeneration process following a sterile injury are conflicting. Here, we show that natural killer (NK) cells are the main source of IFNγ in regenerating muscle. Beyond this cell population, IFNγ production is limited to a small population of T cells. We further show that NK cells do not play a major role in muscle regeneration following an acute injury or in dystrophic mice. Surprisingly, the absence of IFNγ per se also has no effect on muscle regeneration following an acute injury. However, the role of IFNγ is partially unmasked when TNFα is also neutralized, suggesting a compensatory mechanism. Using transgenic mice, we showed that conditional inhibition of IFNGR1 signaling in muscle stem cells or fibro-adipogenic progenitors does not play a major role in muscle regeneration. In contrast to common belief, we found that IFNγ is not present in the early inflammatory phase of the regeneration process but rather peaks when macrophages are acquiring an anti-inflammatory phenotype. Further transcriptomic analysis suggests that IFNγ cooperates with TNFα to regulate the transition of macrophages from pro- to anti-inflammatory states. The absence of the cooperative effect of these cytokines on macrophages, however, does not result in significant regeneration impairment likely due to the presence of other compensatory mechanisms. Our findings support the arising view of IFNγ as a pleiotropic inflammatory regulator rather than an inducer of the inflammatory response.

Indexed as

MacrophagesTumor Necrosis Factor-alphaAnimalsAnti-Inflammatory AgentsCytokinesInterferon-gammaMiceMusclesRegenerationAnti-Inflammatory AgentsCytokinesInterferon-gammaTumor Necrosis Factor-alphaIFNγmacrophagesmuscle regenerationnatural killer cellsTNFα

Identifiers

PMID36279473
PMCPMC9636974
OpenAlexW4307187883

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.